CLINICAL_TRIALS
trial_result
· 2018-09-25
Clinical Trial Update: Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis [Phase 3]
Summary
Phase 3 long-term safety study of glycopyrronium in subjects with primary axillary hyperhidrosis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Journey Medical Corporation | Conditions: Hyperhidrosis | Phase 3 | Status: COMPLETED | Results posted: 2018-09-25